Six of the 73 letters were issued by CBER for unapproved new biologic/drug products, with an emphasis on umbilical cord-derived products and exosome products
Are there safety concerns specific to long-term semaglutide use
Semaglutide (glp-1) injections are a new, groundbreaking innovation used in weight loss treatment It has already shown remarkable results in clinical trials and will indeed prove to be similarly effective in treating your condition
We also place a strong emphasis on accountability and education
Concurrently, the imbalance characterized by reduced beneficial bacteria such as Bifidobacterium and Lactobacillus , and proliferation of opportunistic pathogenic bacteria such as Enterobacteriaceae and Streptococcus significantly disrupts gut immune homeostasis, promoting chronic low-grade inflammation (Liu Y
If you are sitting on the fence wondering whether the safety data holds up in practice, my honest takeaway is that it does